Added Value and Diagnostic Performance of Intratumoral Susceptibility Signals in the Differential Diagnosis of Solitary Enhancing Brain Lesions: Preliminary Study

References

1. ↵
   1. Reichenbach JR,
   2. Jonetz-Mentzel L,
   3. Fitzek C,
   4. et al

   . High-resolution blood oxygen-level dependent MR venography (HRBV): a new technique. Neuroradiology 2001; 43: 364– 69

   CrossRefPubMedWeb of Science
2. ↵
   1. Reichenbach JR,
   2. Essig M,
   3. Haacke EM,
   4. et al

   . High-resolution venography of the brain using magnetic resonance imaging. MAGMA 1998; 6: 62– 69

   CrossRefPubMed
3. ↵
   1. Reichenbach JR,
   2. Haacke EM

   . High-resolution BOLD venographic imaging: a window into brain function. NMR Biomed 2001; 14: 453– 67

   CrossRefPubMedWeb of Science
4. ↵
   1. Sehgal V,
   2. Delproposto Z,
   3. Haacke EM,
   4. et al

   . Clinical applications of neuroimaging with susceptibility-weighted imaging. J Magn Reson Imaging 2005; 22: 439– 50

   CrossRefPubMed
5. ↵
   1. Lee BC,
   2. Vo KD,
   3. Kido DK,
   4. et al

   . MR high-resolution blood oxygenation level dependent venography of occult (low-flow) vascular lesions. AJNR Am J Neuroradiol 1999; 20: 1239– 42

   Abstract/FREE Full Text
6. ↵
   1. de Souza JM,
   2. Domingues RC,
   3. Cruz LC Jr.,
   4. et al

   . Susceptibility-weighted imaging for the evaluation of patients with familial cerebral cavernous malformations: a comparison with T2-weighted fast spin-echo and gradient-echo sequences. AJNR Am J Neuroradiol 2008; 29: 154– 58

   Abstract/FREE Full Text
7. ↵
   1. Sehgal V,
   2. Delproposto Z,
   3. Haddar D,
   4. et al

   . Susceptibility-weighted imaging to visualize blood products and improve tumor contrast in the study of brain masses. J Magn Reson Imaging 2006; 24: 41– 51

   CrossRefPubMed
8. ↵
   1. Barth M,
   2. Nobauer-Huhmann IM,
   3. Reichenbach JR,
   4. et al

   . High-resolution three-dimensional contrast-enhanced blood oxygenation level-dependent magnetic resonance venography of brain tumors at 3 Tesla: first clinical experience and comparison with 1.5 Tesla. Invest Radiol 2003; 38: 409– 14

   CrossRefPubMedWeb of Science
9. ↵
   1. Pinker K,
   2. Noebauer-Huhmann IM,
   3. Stavrou I,
   4. et al

   . High-resolution contrast-enhanced, susceptibility-weighted MR imaging at 3T in patients with brain tumors: correlation with positron-emission tomography and histopathologic findings. AJNR Am J Neuroradiol 2007; 28: 1280– 86

   Abstract/FREE Full Text
10. ↵
    1. Enzinger C,
    2. Strasser-Fuchs S,
    3. Ropele S,
    4. et al

    . Tumefactive demyelinating lesions: conventional and advanced magnetic resonance imaging. Mult Scler 2005; 11: 135– 39

    Abstract/FREE Full Text
11. ↵
    1. Law M,
    2. Meltzer DE,
    3. Cha S

    . Spectroscopic magnetic resonance imaging of a tumefactive demyelinating lesion. Neuroradiology 2002; 44: 986– 98

    CrossRefPubMedWeb of Science
12. ↵
    1. Kwee SA,
    2. Coel MN,
    3. Lim J,
    4. et al

    . Combined use of F-18 fluorocholine positron emission tomography and magnetic resonance spectroscopy for brain tumor evaluation. J Neuroimaging 2004; 14: 285– 89

    CrossRefPubMed
13. ↵
    1. Daumas-Duport C,
    2. Beuvon F,
    3. Varlet P,
    4. et al

    . Gliomas: WHO and Sainte-Anne Hospital classifications. Ann Pathol 2000; 20: 413– 28

    PubMedWeb of Science
14. ↵
    1. Rauscher A,
    2. Sedlacik J,
    3. Barth M,
    4. et al

    . Magnetic susceptibility-weighted MR phase imaging of the human brain. AJNR Am J Neuroradiol 2005; 26: 736– 42

    Abstract/FREE Full Text
15. ↵
    1. Haacke EM,
    2. Xu Y,
    3. Cheng YC,
    4. et al

    . Susceptibility-weighted imaging (SWI). Magn Reson Med 2004; 52: 612– 18

    CrossRefPubMedWeb of Science
16. ↵
    1. Castillo M,
    2. Scatliff JH,
    3. Bouldin TW,
    4. et al

    . Radiologic-pathologic correlation: intracranial astrocytoma. AJNR Am J Neuroradiol 1992; 13: 1609– 16

    FREE Full Text
17. ↵
    1. Dean BL,
    2. Drayer BP,
    3. Bird CR,
    4. et al

    . Gliomas: classification with MR imaging. Radiology 1990; 174: 411– 15

    CrossRefPubMedWeb of Science
18. ↵
    1. Cha S,
    2. Knopp EA,
    3. Johnson G,
    4. et al

    . Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging. Radiology 2002; 223: 11– 29

    CrossRefPubMedWeb of Science
19. ↵
    1. Mittal S,
    2. Wu Z,
    3. Neelavalli J,
    4. et al

    . Susceptibility-weighted imaging: technical aspects and clinical applications, part 2. AJNR Am J Neuroradiol 2009; 30: 232– 52. Epub 2009 Jan 8

    Abstract/FREE Full Text